Feasibility and safety of fertility sparing surgery in epithelial ovarian cancer with dense adhesion: a long term result from a single institution

다국어 초록 (Multilingual Abstract)

Objective: We investigated the feasibility and safety of fertility-sparing surgery (FSS) inpatients with epithelial ovarian cancer (EOC) with dense adhesions.
Methods: Patients were divided into cases with and without dense adhesions in thisretrospective study.
Results: Of the 95 eligible patients, 29 patients had dense adhesions. Mean age, proportionof staging procedure, distribution of histologic type, and co-presence of endometriosis weredifferent (p=0.003, 0.033, 0.011, and 0.011, respectively). The median follow-up period was57.8 (0.4–230.0) months. There were no differences in the rates of recurrence (21.2% vs.
20.7%, p=1.000) or death (16.7% vs. 6.9%, p=0.332) between the 2 groups. There was nodifference in the pattern of recurrence or in disease-free survival (DFS) and overall survival(OS) between the 2 groups. In multivariate analysis, pretreatment cancer antigen-125 >35U/mL and International Federation of Gynecology and Obstetrics stage IC were significantfactors of worse DFS and OS, while dense adhesion was not a prognostic factor for both DFS(hazard ratio [HR]=0.9; 95% confidence interval [CI]=0.3–2.7; p=0.792) and OS (HR=0.2;95% CI=0.1–1.8; p=0.142), nor were age, proportion of staging procedure, histologic type, andco-presence of endometriosis. Moreover, the distribution of those 2 significant prognosticfactors was not different between the 2 groups. Dense adhesions were subgrouped into non tumor and tumor associated dense adhesions for further analysis and the results were same.
Conclusion: FSS is feasible and safe in EOC, regardless of the presence of dense adhesions.

참고문헌 (Reference)

1 Seidman JD, "Upstaging pathologic stage I ovarian carcinoma based on dense adhesions is not warranted : a clinicopathologic study of 84 patients originally classified as FIGO stage II" 119 : 250-254, 2010

2 백이선, "Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification" 대한산부인과학회 58 (58): 124-134, 2015

3 Prat J, "Staging classification for cancer of the ovary, fallopian tube, and peritoneum" 124 : 1-5, 2014

4 Kajiyama H, "Recurrence-predicting prognostic factors for patients with early-stage epithelial ovarian cancer undergoing fertility-sparing surgery : a multi-institutional study" 175 : 97-102, 2014

5 Tropé C, "Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument" 11 : 281-288, 2000

6 Vergote I, "Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma" 357 : 176-182, 2001

7 Dembo AJ, "Prognostic factors in patients with stage I epithelial ovarian cancer" 75 : 263-273, 1990

8 Plaxe SC, "Profiles of women age 30-39 and age less than 30 with epithelial ovarian cancer" 81 : 651-654, 1993

9 Ozols RF, "Principles and practice of gynecologic oncology" Lippincott, Williams & Wilkins 927-, 2003

10 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2015" 대한암학회 47 (47): 142-148, 2015

11 Satoh T, "Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer : a proposal for patient selection" 28 : 1727-1732, 2010

12 Park JY, "Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer : oncologic safety and reproductive outcomes" 110 : 345-353, 2008

13 American College of Obstetricians and Gynecologists, "Management of adnexal masses" 110 : 201-214, 2007

14 Schlaerth AC, "Long-term survival after fertility-sparing surgery for epithelial ovarian cancer" 19 : 1199-1204, 2009

15 Cho YH, "Is complete surgical staging necessary in patients with stage I mucinous epithelial ovarian tumors?" 103 : 878-882, 2006

16 임명철, "Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010" 대한부인종양학회 24 (24): 298-302, 2013

17 Kajiyama H, "Fertility-sparing surgery in young women with invasive epithelial ovarian cancer" 36 : 404-408, 2010

18 Antonino Ditto, "Fertility sparing surgery in early stage epithelial ovarian cancer" 대한부인종양학회 25 (25): 320-327, 2014

19 "FIGO (International Federation of Gynecology and Obstetrics) annual report on the results of treatment in gynecological cancer" 83 (83): ix-xxii, 2003

20 Aebi S, "Epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up" 19 (19): ii14-16, 2008

21 Zapardiel I, "Conservative treatment of early stage ovarian cancer : oncological and fertility outcomes" 40 : 387-393, 2014

22 Morice P, "Conservative treatment in epithelial ovarian cancer : results of a multicentre study of the GCCLCC(Groupe des Chirurgiens de Centre de Lutte Contre le Cancer)and SFOG(Société Francaise d'Oncologie Gynécologique)" 20 : 1379-1385, 2005

23 Raspagliesi F, "Conservative surgery in high-risk epithelial ovarian carcinoma" 185 : 457-460, 1997

24 Zanetta G, "Conservative surgery for stage I ovarian carcinoma in women of childbearing age" 104 : 1030-1035, 1997

25 Fruscio R, "Conservative management of early-stage epithelial ovarian cancer : results of a large retrospective series" 24 : 138-144, 2013

26 Heintz AP, "Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer" 95 (95): S161-192, 2006

27 Greenlee RT, "Cancer statistics, 2001" 51 : 15-36, 2001

28 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012" 대한암학회 47 (47): 127-141, 2015

29 Vergote IB, "Analysis of prognostic factors in stage I epithelial ovarian carcinoma : importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse" 169 : 40-52, 1993